[{"address1": "Wagistrasse 14", "city": "Schlieren", "zip": "8952", "country": "Switzerland", "phone": "41 44 755 77 00", "fax": "41 44 755 77 07", "website": "https://www.molecularpartners.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Molecular Partners AG, a clinical-stage biotechnology company, develops designed ankyrin repeat proteins therapeutics for the treatment of oncology and virology diseases in Switzerland. The company develops MP0317, a CD40 agonist designed to activate immune cells within the tumor microenvironment by anchoring to fibroblast activation protein that is in Phase I clinical trial; and MP0533, a novel tetra-specific T cell-engaging DARPin for acute myeloid leukemia. It also develops Switch-DARPin platform, a multispecific cKIT x CD16a x CD47 Switch-DARPin program for targeted and conditional immune cell activation; and Radio-DARPin Therapy (RDT) platform, a delivery system for effective and selective delivery of radioactive payloads to solid tumors. It has license and research collaboration agreements with Novartis Pharma AG to develop DARPin-conjugated radioligand therapies; and collaboration agreement with Orano Med SAS to develop novel Radio-DARPin therapeutics. Molecular Partners AG was incorporated in 2004 and is headquartered in Schlieren, Switzerland.", "fullTimeEmployees": 158, "companyOfficers": [{"maxAge": 1, "name": "Dr. Patrick  Amstutz Ph.D.", "age": 49, "title": "Co-Founder, CEO, Member of Management Board & Director", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 739727, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael Tobias Stumpp Ph.D.", "age": 52, "title": "Co-Founder, Executive VP of Projects & Member of Management Board", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert  Hendriks", "title": "Senior VP of Finance", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alexander  Zurcher", "age": 49, "title": "COO & Member of Management Board", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Renate  Gloggner", "age": 54, "title": "Executive VP of People & Community and Member of Management Board", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Philippe  Legenne M.B.A., M.D.", "age": 58, "title": "Chief Medical Officer & Member of the Management Board", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel  Steiner Ph.D.", "title": "Senior Vice President of Research & Technology", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Seth D. Lewis", "title": "Senior Vice President of Investor Relations, Communications & Strategy", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  Pitzner", "title": "General Counsel, Compliance Officer, Senior VP Legal & Business Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Pamela A. Trail Ph.D.", "age": 68, "title": "Strategic Consultant", "yearBorn": 1956, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.76, "open": 4.08, "dayLow": 4.08, "dayHigh": 4.32, "regularMarketPreviousClose": 3.76, "regularMarketOpen": 4.08, "regularMarketDayLow": 4.08, "regularMarketDayHigh": 4.32, "payoutRatio": 0.0, "beta": 0.629, "forwardPE": -2.2391303, "volume": 3614, "regularMarketVolume": 3614, "averageVolume": 3893, "averageVolume10days": 5200, "averageDailyVolume10Day": 5200, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 157465568, "fiftyTwoWeekLow": 3.32, "fiftyTwoWeekHigh": 12.7, "priceToSalesTrailing12Months": 31.683212, "fiftyDayAverage": 4.9934, "twoHundredDayAverage": 5.61587, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -8389763, "profitMargins": 0.0, "floatShares": 14882000, "sharesOutstanding": 36874600, "sharesShort": 43144, "sharesShortPriorMonth": 46351, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.0011999999, "heldPercentInsiders": 0.0, "heldPercentInstitutions": 0.097229995, "shortRatio": 26.8, "shortPercentOfFloat": 0.0023999999, "impliedSharesOutstanding": 38219800, "bookValue": 3.842, "priceToBook": 1.0723581, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -54043000, "trailingEps": -1.8, "forwardEps": -1.84, "enterpriseToRevenue": -1.688, "enterpriseToEbitda": 0.139, "52WeekChange": -0.030927837, "SandP52WeekChange": 0.07465422, "quoteType": "EQUITY", "currentPrice": 4.12, "targetHighPrice": 16.999645, "targetLowPrice": 4.531949, "targetMeanPrice": 10.648259, "targetMedianPrice": 10.530719, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 149439008, "totalCashPerShare": 4.054, "ebitda": -60229000, "totalDebt": 2444000, "quickRatio": 13.959, "currentRatio": 14.305, "totalRevenue": 4970000, "debtToEquity": 1.726, "revenuePerShare": 0.146, "returnOnAssets": -0.21441999, "returnOnEquity": -0.33982, "grossProfits": -42534000, "freeCashflow": -35437248, "operatingCashflow": -59248000, "revenueGrowth": -1.0, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -12.3173, "financialCurrency": "CHF", "symbol": "MOLN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketTime": 1742410295, "regularMarketChangePercent": 9.574465, "regularMarketPrice": 4.12, "shortName": "Molecular Partners AG", "longName": "Molecular Partners AG", "corporateActions": [], "exchange": "NMS", "messageBoardId": "finmb_32677064", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "REGULAR", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1623850200000, "regularMarketChange": 0.3599999, "regularMarketDayRange": "4.08 - 4.32", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 3893, "fiftyTwoWeekLowChange": 0.79999995, "fiftyTwoWeekLowChangePercent": 0.24096385, "fiftyTwoWeekRange": "3.32 - 12.7", "fiftyTwoWeekHighChange": -8.58, "fiftyTwoWeekHighChangePercent": -0.6755906, "fiftyTwoWeekChangePercent": -3.0927837, "earningsTimestamp": 1741294800, "earningsTimestampStart": 1741294800, "earningsTimestampEnd": 1741294800, "earningsCallTimestampStart": 1741345140, "earningsCallTimestampEnd": 1741345140, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.8, "epsForward": -1.84, "epsCurrentYear": -1.47838, "priceEpsCurrentYear": -2.7868342, "fiftyDayAverageChange": -0.8734002, "fiftyDayAverageChangePercent": -0.17491092, "twoHundredDayAverageChange": -1.4958701, "twoHundredDayAverageChangePercent": -0.2663648, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-06-16", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "trailingPegRatio": null, "__fetch_time": "2025-03-19"}]